MED15 and posterior cortical atrophy: Our previous results showing MED15 overexpression to correlate with worse clinical outcome [12], to affect proliferative activity of PCa cells and TGFß driven proliferation [12], provides evidence that MED15 drives oncogenic properties of advanced PCa and CRPC cells.